Naz Rahman
Stock Analyst at Maxim Group
(0.10)
# 4,579
Out of 4,639 analysts
464
Total ratings
39%
Success rate
-6.8%
Average return
Main Sectors:
Stocks Rated by Naz Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Reiterated: Buy | $8 | $2.04 | +292.16% | 32 | Aug 12, 2026 | |
| VANI Vivani Medical | Reiterated: Buy | $4 | $1.37 | +193.04% | 27 | Aug 7, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $575 | $529.64 | +8.56% | 35 | Aug 5, 2026 | |
| NVCT Nuvectis Pharma | Reiterated: Buy | $30 | $19.60 | +53.06% | 15 | Aug 5, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $70 | $34.56 | +102.55% | 38 | Jul 31, 2026 | |
| SLXN Silexion Therapeutics | Downgraded: Hold | n/a | $0.45 | - | 24 | Jul 30, 2026 | |
| EPA: ADOC Adocia SA | Reiterated: Buy | €16.00 → €12.00 | €4.10 | +192.40% | 7 | Jul 27, 2026 | |
| KZIA Kazia Therapeutics | Reiterated: Buy | $30 | $13.88 | +116.22% | 14 | Jul 15, 2026 | |
| QNRX Quoin Pharmaceuticals | Reiterated: Buy | $16 | $5.50 | +190.91% | 34 | Jul 10, 2026 | |
| SCNX Scienture Holdings | Reiterated: Buy | $1.5 | $0.42 | +257.14% | 3 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.5637 | - | 13 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $9.00 | +33.41% | 2 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.11 | +56.56% | 27 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.395098 | +406.20% | 33 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.38 | +117.39% | 13 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $2.39 | +192.89% | 20 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.05 | +394.44% | 33 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 | $0.3001 | +399.83% | 2 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.52 | - | 15 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.48005 | n/a | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.0032 | n/a | 11 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.03 | n/a | 21 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0001 | n/a | 11 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.13 | n/a | 6 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.10 | n/a | 3 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $9.92 | n/a | 1 | Aug 12, 2021 |
Palisade Bio
Aug 12, 2026
Reiterated: Buy
Price Target: $8
Current: $2.04
Upside: +292.16%
Vivani Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $4
Current: $1.37
Upside: +193.04%
Vertex Pharmaceuticals
Aug 5, 2026
Reiterated: Buy
Price Target: $575
Current: $529.64
Upside: +8.56%
Nuvectis Pharma
Aug 5, 2026
Reiterated: Buy
Price Target: $30
Current: $19.60
Upside: +53.06%
Viking Therapeutics
Jul 31, 2026
Reiterated: Buy
Price Target: $70
Current: $34.56
Upside: +102.55%
Silexion Therapeutics
Jul 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.45
Upside: -
Adocia SA
Jul 27, 2026
Reiterated: Buy
Price Target: €16.00 → €12.00
Current: €4.10
Upside: +192.40%
Kazia Therapeutics
Jul 15, 2026
Reiterated: Buy
Price Target: $30
Current: $13.88
Upside: +116.22%
Quoin Pharmaceuticals
Jul 10, 2026
Reiterated: Buy
Price Target: $16
Current: $5.50
Upside: +190.91%
Scienture Holdings
Jul 9, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.42
Upside: +257.14%
Jun 10, 2026
Maintained: Hold
Price Target: n/a
Current: $0.5637
Upside: -
Jun 10, 2026
Reiterated: Buy
Price Target: $12
Current: $9.00
Upside: +33.41%
Jun 3, 2026
Reiterated: Buy
Price Target: $8
Current: $5.11
Upside: +56.56%
May 19, 2026
Reiterated: Buy
Price Target: $2
Current: $0.395098
Upside: +406.20%
May 15, 2026
Reiterated: Buy
Price Target: $3
Current: $1.38
Upside: +117.39%
May 15, 2026
Rated: Buy
Price Target: $7
Current: $2.39
Upside: +192.89%
May 15, 2026
Reiterated: Buy
Price Target: $20
Current: $4.05
Upside: +394.44%
May 14, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.3001
Upside: +399.83%
Nov 19, 2025
Maintained: Hold
Price Target: n/a
Current: $2.52
Upside: -
Aug 7, 2025
Maintained: Hold
Price Target: n/a
Current: $0.48005
Upside: n/a
Dec 18, 2024
Maintained: Buy
Price Target: n/a
Current: $0.0032
Upside: n/a
Nov 20, 2024
Maintained: Hold
Price Target: n/a
Current: $1.03
Upside: n/a
May 17, 2023
Maintained: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 10, 2022
Maintained: Hold
Price Target: n/a
Current: $6.13
Upside: n/a
Jan 13, 2022
Maintained: Hold
Price Target: n/a
Current: $3.10
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $6
Current: $9.92
Upside: n/a